Literature DB >> 27252255

Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015.

E K L Chan1, J Damoiseaux2, W de Melo Cruvinel3, O G Carballo4, K Conrad5, P L C Francescantonio3, M J Fritzler6, I Garcia-De La Torre7, M Herold8, T Mimori9, M Satoh10, C A von Mühlen11, L E C Andrade12.   

Abstract

The second meeting for the International Consensus on Antinuclear antibody (ANA) Pattern (ICAP) was held on 22 September 2015, one day prior to the opening of the 12th Dresden Symposium on Autoantibodies in Dresden, Germany. The ultimate goal of ICAP is to promote harmonization and understanding of autoantibody nomenclature, and thereby optimizing ANA usage in patient care. The newly developed ICAP website www.ANApatterns.org was introduced to the more than 50 participants. This was followed by several presentations and discussions focusing on key issues including the two-tier classification of ANA patterns into competent-level versus expert-level, the consideration of how to report composite versus mixed ANA patterns, and the necessity for developing a consensus on how ANA results should be reported. The need to establish on-line training modules to help users gain competency in identifying ANA patterns was discussed as a future addition to the website. To advance the ICAP goal of promoting wider international participation, it was agreed that there should be a consolidated plan to translate consensus documents into other languages by recruiting help from members of the respective communities.
© The Author(s) 2016.

Entities:  

Keywords:  Antinuclear antibodies; autoantibodies; autoimmunity; consensus; standardization

Mesh:

Substances:

Year:  2016        PMID: 27252255     DOI: 10.1177/0961203316640920

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  18 in total

1.  Biomarkers and Pathogenic Mechanisms in Autoimmunity.

Authors:  Edward K L Chan; Elias Toubi; Karsten Conrad
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 2.  Recent Approaches To Optimize Laboratory Assessment of Antinuclear Antibodies.

Authors:  Anne E Tebo
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

3.  Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.

Authors:  Angela Ceribelli; Natasa Isailovic; Maria De Santis; Elena Generali; Micaela Fredi; Ilaria Cavazzana; Franco Franceschini; Luca Cantarini; Minoru Satoh; Carlo Selmi
Journal:  Clin Rheumatol       Date:  2016-10-20       Impact factor: 2.980

Review 4.  Antinuclear antibody testing - misunderstood or misbegotten?

Authors:  David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2017-05-25       Impact factor: 20.543

5.  How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative.

Authors:  Carlos Alberto von Mühlen; Ignacio Garcia-De La Torre; Maria Infantino; Jan Damoiseaux; Luis E C Andrade; Orlando Gabriel Carballo; Karsten Conrad; Paulo Luiz Carvalho Francescantonio; Marvin J Fritzler; Manfred Herold; Werner Klotz; Wilson de Melo Cruvinel; Tsuneyo Mimori; Minoru Satoh; Lucile Musset; Edward K L Chan
Journal:  Immunol Res       Date:  2021-10-09       Impact factor: 2.829

6.  Autoimmunity in Human CE: Correlative with The Fertility Status of The CE Cyst.

Authors:  E A El Saftawy; A Abdelraouf; M A Elsalam; P Zakareya; A Fouad; E A Albadawi; A H S Abobakr Ali; N M Amin
Journal:  Helminthologia       Date:  2022-05-04       Impact factor: 1.176

7.  Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.

Authors:  May Y Choi; Ann E Clarke; Yvan St Pierre; John G Hanly; Murray B Urowitz; Juanita Romero-Diaz; Caroline Gordon; Sang-Cheol Bae; Sasha Bernatsky; Daniel J Wallace; Joan T Merrill; David A Isenberg; Anisur Rahman; Ellen M Ginzler; Michelle Petri; Ian N Bruce; Mary A Dooley; Paul R Fortin; Dafna D Gladman; Jorge Sanchez-Guerrero; Kristjan Steinsson; Rosalind Ramsey-Goldman; Munther A Khamashta; Cynthia Aranow; Graciela S Alarcón; Susan Manzi; Ola Nived; Asad A Zoma; Ronald F van Vollenhoven; Manuel Ramos-Casals; Guillermo Ruiz-Irastorza; S Sam Lim; Kenneth C Kalunian; Murat Inanc; Diane L Kamen; Christine A Peschken; Soren Jacobsen; Anca Askanase; Thomas Stoll; Jill Buyon; Michael Mahler; Marvin J Fritzler
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-06-12       Impact factor: 4.794

Review 8.  Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems.

Authors:  Luigi Cinquanta; Nicola Bizzaro; Giampaola Pesce
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

9.  Detection of autoantibodies to DSF70/LEDGFp75 in Mexican Hispanics using multiple complementary assay platforms.

Authors:  Mónica Vázquez-Del Mercado; Eduardo Gómez-Bañuelos; Rosa Elena Navarro-Hernández; Oscar Pizano-Martinez; Adan Saldaña-Millán; Efrain Chavarria-Avila; Lorena Gonzalez-Rosas; Lilia Andrade-Ortega; Miguel Angel Saavedra; Olga Lidia Vera-Lastra; Luis Javier Jara; Gabriel Medrano-Ramírez; Claudia Cruz-Reyes; Ignacio García-De la Torre; Marta Escarra-Senmarti; Lisiane Maria Enriconi-Dos Anjos; Anamika Basu; Roger Albesa; Michael Mahler; Carlos A Casiano
Journal:  Auto Immun Highlights       Date:  2016-11-24

Review 10.  Emerging technologies in autoantibody testing for rheumatic diseases.

Authors:  Nancy J Olsen; May Y Choi; Marvin J Fritzler
Journal:  Arthritis Res Ther       Date:  2017-07-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.